Baseline characteristics of each study population (non-DM vs T2DM)
| Study population A (overall population) | Study population B (laboratory data-available admissions only) | |||||
|---|---|---|---|---|---|---|
| non-DM | T2DM | p Value* | non-DM | T2DM | p Value* | |
| Number of admission | 306 100 | 260 091 | 259 633 | 53 793 | ||
| Male, % | 54.6% | 67.7% | <0.0001 | 53.0% | 67.9% | <0.0001 |
| Age, years (mean±SD) | 60.3±15.2 | 66.9±9.7 | <0.0001 | 59.4±15.6 | 66.7±9.8 | <0.0001 |
| Admission year | ||||||
| 2010 | 14.1% | 10.9% | <0.0001 | 13.2% | 10.7% | <0.0001 |
| 2011 | 19.3% | 16.3% | 18.8% | 18.0% | ||
| 2012 | 22.8% | 20.9% | 22.5% | 23.2% | ||
| 2013 | 26.0% | 29.9% | 26.2% | 28.3% | ||
| 2014 | 17.7% | 22.0% | 19.2% | 19.9% | ||
| Concomitant diseases | ||||||
| Neural | 28.7% | 39.3% | <0.0001 | 28.3% | 39.1% | <0.0001 |
| Eye | 8.1% | 24.0% | <0.0001 | 7.8% | 24.0% | <0.0001 |
| Cardiovascular | 45.9% | 78.6% | <0.0001 | 43.5% | 78.3% | <0.0001 |
| Respiratory | 25.6% | 34.3% | <0.0001 | 24.8% | 33.1% | <0.0001 |
| Gastrointestinal | 63.7% | 75.4% | <0.0001 | 62.3% | 75.4% | <0.0001 |
| Renal | 22.6% | 32.8% | <0.0001 | 22.1% | 32.5% | <0.0001 |
| Sepsis | 1.6% | 3.5% | <0.0001 | 1.4% | 3.0% | <0.0001 |
| Non-septic severe infection | 5.6% | 6.9% | <0.0001 | 5.6% | 6.8% | <0.0001 |
| Solid tumour | 36.6% | 31.6% | <0.0001 | 37.1% | 35.6% | <0.0001 |
| Acute leukaemia | 0.6% | 0.6% | 0.21 | 0.4% | 0.7% | <0.0001 |
*T2DM versus non-DM. p Values were calculated by t-test for age and by χ2 test for variables other than age.
T2DM, type 2 diabetes mellitus.